Robuta

Cancer is not treated equally successfully in Western Europe (WE) and in Central and Eastern Europe (CEE). This study showed that success in treatment of...

Agents targeting nuclear kinases appear to be effective in SCLC lines. Confirmation of SCLC line findings in xenografts is needed. The drug and compound...

The most lucrative geographies for new oncology drugs seem to be those in which there is a shorter timeframe to peak sales.

Explore global open-access research on anti-cancer drug pharmacology, advancing therapies for cancer and benign tumors through innovative drug development.

TBRC oncology drugs market report includes lung cancer, pancreatic cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric cancer,...

LAMEA Oncology/anti-cancer drugs market share expected to reach $17,072.2 million. Rising government funds is major factors boosting the market growth

The global oncology drugs market size is projected to grow from $267.24 billion in 2026 to $667.28 billion by 2034, at a CAGR of 12.12%

Mexico Oncology Drugs Market size was valued at USD 3.9 Bn. in 2023 and the Mexico Oncology Drugs revenue is expected to grow at a CAGR of 11%